Related references
Note: Only part of the references are listed.Neuropsychiatric clinical manifestations in elderly patients treated with hydroxychloroquine: a review article
Annamaria Mascolo et al.
INFLAMMOPHARMACOLOGY (2018)
Increase in serum HDL level is associated with less negative symptoms after one year of antipsychotic treatment in first-episode psychosis
Priyanthi B. Gjerde et al.
SCHIZOPHRENIA RESEARCH (2018)
Theranostic Biomarkers for Schizophrenia
Matea Nikolac Perkovic et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Lipid profile disturbances in antipsychotic-naive patients with first-episode non-affective psychosis: A systematic review and meta-analysis
Blazej Misiak et al.
SCHIZOPHRENIA RESEARCH (2017)
Elevated levels of Insulin-like Growth Factor-1 (IGF-1) in drug-naive patients with psychosis
Petros Petrikis et al.
PSYCHIATRY RESEARCH (2016)
Metabolic syndrome in people with schizophrenia: a review
MARC DE HERT et al.
World Psychiatry (2015)
Relationships between IGF-1, schizophrenia, and treatment of metabolic syndrome
Aysegul Demirel et al.
COMPREHENSIVE PSYCHIATRY (2014)
Insulin, IGF-1 and GLP-1 signaling in neurodegenerative disorders: Targets for disease modification?
Fares Bassil et al.
PROGRESS IN NEUROBIOLOGY (2014)
Biomarkers in Schizophrenia: A Brief Conceptual Consideration
Cynthia S. Weickert et al.
DISEASE MARKERS (2013)
Predictors of short - and long-term clinical outcome in schizophrenic psychosis - the Northern Finland 1966 Birth Cohort study
P. Juola et al.
EUROPEAN PSYCHIATRY (2013)
Relationship between negative symptoms and plasma levels of insulin-like growth factor 1 in first-episode schizophrenia and bipolar disorder patients
Aitor Palomino et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2013)
Schizophrenia: Metabolic aspects of aetiology, diagnosis and future treatment strategies
Laura W. Harris et al.
PSYCHONEUROENDOCRINOLOGY (2013)
Elevated levels of adiponectin and other cytokines in drug naive, first episode schizophrenia patients with normal weight
Xueqin Song et al.
SCHIZOPHRENIA RESEARCH (2013)
Employment and its relationship with functionality and quality of life in patients with schizophrenia: EGOFORS Study
A. Ucok et al.
EUROPEAN PSYCHIATRY (2012)
Comparison of Peripheral and Central Schizophrenia Biomarker Profiles
Laura W. Harris et al.
PLOS ONE (2012)
Global assessment of psychosocial functioning and predictors of outcome in schizophrenia
Evgenia Stefanopoulou et al.
INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE (2011)
Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling
Aileen M. Moloney et al.
NEUROBIOLOGY OF AGING (2010)
Are metabolic indices different between drug-naive first-episode psychosis patients and healthy controls?
Sarojini Sengupta et al.
SCHIZOPHRENIA RESEARCH (2008)
Similarities and differences between insulin and IGF-I: Structures, receptors, and signalling pathways
Haim Werner et al.
ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY (2008)
Glucose-insulin homeostasis, lipid profiles and GH-IGF-IGFBP axis in clozapine-treated schizophrenic obesity versus non-psychiatric obesity
M-K Wu et al.
INTERNATIONAL JOURNAL OF OBESITY (2008)
Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles
H. A. Nasrallah
MOLECULAR PSYCHIATRY (2008)
Impaired glucose tolerance in first-episode drug-naive patients with schizophrenia
L. M. Spelman et al.
DIABETIC MEDICINE (2007)
IGF1, growth pathway polymorphisms and schizophrenia: A pooling study
D. Gunnell et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2007)
Abdominal obesity and metabolic syndrome
Jean-Pierre Despres et al.
NATURE (2006)
Remission in schizophrenia: Proposed criteria and rationale for consensus
NC Andreasen et al.
AMERICAN JOURNAL OF PSYCHIATRY (2005)
Nicotine use in schizophrenia: The self medication hypotheses
V Kumari et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2005)
The role of insulin and insulin-like growth factor I in the molecular and cellular mechanisms underlying the pathology of Alzheimer's disease
E Carro et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2004)
Do insulin-like growth factors underlie associations of birth complications, fetal and pre-adult growth with schizophrenia?
D Gunnell et al.
SCHIZOPHRENIA RESEARCH (2004)
IGF-1 instructs multipotent adult neural progenitor cells to become oligodendrocytes
J Hsieh et al.
JOURNAL OF CELL BIOLOGY (2004)
IGF-1 and NT-3 signaling pathways in developing oligodendrocytes: Differential regulation and activation of receptors and the downstream effector Akt
JK Ness et al.
DEVELOPMENTAL NEUROSCIENCE (2002)
Schizophrenia and tobacco smoking: a replication study in another US psychiatric hospital
J de Leon et al.
SCHIZOPHRENIA RESEARCH (2002)
A genome-wide scan for linkage to chromosomal regions in 382 sibling pairs with schizophrenia or schizoaffective disorder
LE DeLisi et al.
AMERICAN JOURNAL OF PSYCHIATRY (2002)
Duration of untreated psychosis as a predictor of outcome in first-episode schizophrenia: a retrospective study
AC Altamura et al.
SCHIZOPHRENIA RESEARCH (2001)
Incidence of cancer among persons with schizophrenia and their relatives
D Lichtermann et al.
ARCHIVES OF GENERAL PSYCHIATRY (2001)
Share Paper
